A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effe...
Saved in:
Published in | Emerging microbes & infections Vol. 10; no. 1; pp. 894 - 904 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.01.2021
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effective and high-throughput neutralization test is urgently needed. Conventional SARS-CoV-2 neutralization test is tedious, time-consuming and requires a biosafety level 3 laboratory. Despite recent reports of neutralizations using different pseudoviruses with a luciferase or green fluorescent protein reporter, the laborious steps, inter-assay variability or high background limit their high-throughput potential. In this study we generated lentivirus-based pseudoviruses containing a monomeric infrared fluorescent protein reporter to develop neutralization assays. Similar tropism, infection kinetics and mechanism of entry through receptor-mediated endocytosis were found in the three pseudoviruses generated. Compared with pseudovirus D614, pseudovirus with D614G mutation had decreased shedding and higher density of S1 protein present on particles. The 50% neutralization titers to pseudoviruses D614 or D614G correlated with the plaque reduction neutralization titers to live SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence, one-step image quantification, expandable to 384-well, sequential readouts and dual quantifications by flow cytometry support its high-throughput and versatile applications at a non-reference and biosafety level 2 laboratory, in particular for assessing the neutralization sensitivity of new variants by sera from natural infection or different vaccinations during our fight against the pandemic. |
---|---|
AbstractList | Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effective and high-throughput neutralization test is urgently needed. Conventional SARS-CoV-2 neutralization test is tedious, time-consuming and requires a biosafety level 3 laboratory. Despite recent reports of neutralizations using different pseudoviruses with a luciferase or green fluorescent protein reporter, the laborious steps, inter-assay variability or high background limit their high-throughput potential. In this study we generated lentivirus-based pseudoviruses containing a monomeric infrared fluorescent protein reporter to develop neutralization assays. Similar tropism, infection kinetics and mechanism of entry through receptor-mediated endocytosis were found in the three pseudoviruses generated. Compared with pseudovirus D614, pseudovirus with D614G mutation had decreased shedding and higher density of S1 protein present on particles. The 50% neutralization titers to pseudoviruses D614 or D614G correlated with the plaque reduction neutralization titers to live SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence, one-step image quantification, expandable to 384-well, sequential readouts and dual quantifications by flow cytometry support its high-throughput and versatile applications at a non-reference and biosafety level 2 laboratory, in particular for assessing the neutralization sensitivity of new variants by sera from natural infection or different vaccinations during our fight against the pandemic. |
Author | Tsai, Wen-Yang Nerurkar, Vivek R. Hsieh, Szu-Chia Wang, Wei-Kung Ching, Lauren L. Melish, Marian E. |
Author_xml | – sequence: 1 givenname: Wen-Yang surname: Tsai fullname: Tsai, Wen-Yang organization: John A. Burns School of Medicine, University of Hawaii at Manoa – sequence: 2 givenname: Lauren L. surname: Ching fullname: Ching, Lauren L. organization: John A. Burns School of Medicine, University of Hawaii at Manoa – sequence: 3 givenname: Szu-Chia surname: Hsieh fullname: Hsieh, Szu-Chia organization: John A. Burns School of Medicine, University of Hawaii at Manoa – sequence: 4 givenname: Marian E. surname: Melish fullname: Melish, Marian E. organization: John A. Burns School of Medicine – sequence: 5 givenname: Vivek R. surname: Nerurkar fullname: Nerurkar, Vivek R. organization: John A. Burns School of Medicine, University of Hawaii at Manoa – sequence: 6 givenname: Wei-Kung orcidid: 0000-0002-6670-4663 surname: Wang fullname: Wang, Wei-Kung email: wangwk@hawaii.edu organization: John A. Burns School of Medicine, University of Hawaii at Manoa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33929934$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Udtu1DAQjVARLaWfAPIPZLFj5-IXxGpFoVIlJAq8Wl5fEleJHY2dVuUv-sc4bFu1L8yDLzPnnLHnvC2OfPCmKN4TvCG4wx-rHKStyabCFdkQXtWkoa-KkzVfroWjZ-fj4izGa5yjxQ0j7E1xTCmvOKfspLjfIjByLJObDJJeo8H1Q5kGCEs_zEtC3iwJ5Oj-yOSCR8nEhPYyGo3y7Wr746rchd9lheZoFh1uHCwRqeCTdN75Hk3Bh8mAU8h5CxIyz45LABOV8QnNEJJxHsmYnzEHSAbeFa-tHKM5e9hPi1_nX37uvpWX379e7LaXpaopS2VLuDUWVzVrlG40by3dW8aM7Borm4Yyxg3lWGHNG07ySlSGWia1wpx1mp4WFwddHeS1mMFNEu5EkE78SwTohYTk1GhEHnZnLaGdsZwxpmUnCaOEUtzajnGStT4dtOZlPxm9fi3P7IXoy4p3g-jDjeiyTlPVWaA-CCgIMYKxT1yCxWq5eLRcrJaLB8sz78Pzxk-sR4Mz4PMBkMcfYJK3AUYtkrwbA2Q_vHJR0P_3-AsOw7-4 |
CitedBy_id | crossref_primary_10_4110_in_2021_21_e39 crossref_primary_10_1007_s00216_021_03806_6 crossref_primary_10_3389_fmed_2022_1019490 crossref_primary_10_1016_j_ijid_2023_11_036 crossref_primary_10_1111_sji_13088 crossref_primary_10_1016_j_vaccine_2022_01_021 crossref_primary_10_1128_spectrum_04081_22 crossref_primary_10_3390_v14102087 crossref_primary_10_1016_j_jcv_2022_105185 |
Cites_doi | 10.1038/s41467-020-15562-9 10.1038/s41586-020-2571-7 10.1126/science.abc6284 10.1038/s41587-020-0631-z 10.1016/j.molcel.2020.04.022 10.1056/NEJMoa2001017 10.1016/S1387-2656(05)11007-2 10.3390/v12050513 10.1371/journal.pone.0045851 10.21769/BioProtoc.2940 10.1080/22221751.2019.1682948 10.1073/pnas.77.7.3884 10.1038/s41586-020-2012-7 10.1016/j.cell.2020.06.043 10.1016/j.virol.2007.06.026 10.1016/j.cell.2020.06.025 10.1016/j.cell.2020.02.058 10.1016/j.chom.2020.11.012 10.1084/jem.20201181 10.1038/s41467-020-19808-4 10.1038/nbt.1918 10.1093/infdis/jiaa673 10.1007/s00259-008-0870-6 10.4161/cc.26985 10.1038/nmeth.2521 10.1038/s41591-021-01255-3 10.1073/pnas.0809524106 10.1006/viro.1995.1016 10.1016/j.celrep.2020.03.002 10.1038/s41467-019-13897-6 10.1038/s41586-020-03041-6 10.1126/science.abf2946 10.1073/pnas.2003138117 10.1128/JVI.00556-18 10.1038/s41586-020-2548-6 10.1074/jbc.M114.610428 10.1126/science.abb2507 10.1073/pnas.0306446101 10.1038/s41423-020-00605-4 10.1016/j.cell.2020.12.015 10.1016/j.antiviral.2020.104742 10.1128/JCM.02107-20 |
ContentType | Journal Article |
Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
DBID | 0YH CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM DOA |
DOI | 10.1080/22221751.2021.1925163 |
DatabaseName | Taylor & Francis Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
DocumentTitleAlternate | Emerging Microbes & Infections |
EISSN | 2222-1751 |
EndPage | 904 |
ExternalDocumentID | oai_doaj_org_article_2218ff138ef9444da8a14313307f8491 10_1080_22221751_2021_1925163 33929934 1925163 |
Genre | Coronaviruses Journal Article |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: P30 GM114737 – fundername: NIAID NIH HHS grantid: R01 AI149502 – fundername: NINR NIH HHS grantid: R01 NR004569 – fundername: NIAID NIH HHS grantid: R21 AI135292 |
GroupedDBID | 0YH 3V. 53G 5VS 7X7 8FI ACGFS ADBBV ADRAZ AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI DIK EBS ECGQY EMOBN FYUFA GROUPED_DOAJ HYE KQ8 M1P M48 M4Z M~E NAO OK1 PIMPY PQEST PQQKQ PQUKI PROAC RNT RNTTT RPM UKHRP 88E 8FJ AAHBH ABUWG ACSMW AJTQC ALIPV BCNDV C6C CCPQU CGR CUY CVF ECM EIF EJD HMCUK NPM PSQYO TDBHL AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c534t-719fef02546cd6d97f3bf44ea86fa663449e390c0d96910d91c546f4adc0948d3 |
IEDL.DBID | RPM |
ISSN | 2222-1751 |
IngestDate | Tue Oct 22 15:01:13 EDT 2024 Tue Sep 17 20:40:05 EDT 2024 Fri Aug 23 03:27:17 EDT 2024 Sat Nov 02 12:28:12 EDT 2024 Tue Jul 04 18:17:09 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | monomeric infrared fluorescent protein pseudovirus SARS-CoV-2 reporter neutralization |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c534t-719fef02546cd6d97f3bf44ea86fa663449e390c0d96910d91c546f4adc0948d3 |
Notes | Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2021.1925163 |
ORCID | 0000-0002-6670-4663 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143625/ |
PMID | 33929934 |
PageCount | 11 |
ParticipantIDs | crossref_primary_10_1080_22221751_2021_1925163 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8143625 informaworld_taylorfrancis_310_1080_22221751_2021_1925163 pubmed_primary_33929934 doaj_primary_oai_doaj_org_article_2218ff138ef9444da8a14313307f8491 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Emerging microbes & infections |
PublicationTitleAlternate | Emerg Microbes Infect |
PublicationYear | 2021 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | CIT0030 CIT0010 CIT0032 CIT0031 CIT0012 CIT0034 CIT0011 CIT0033 V'kovski P (CIT0004) 2020; 28 CIT0014 CIT0036 CIT0013 CIT0035 CIT0016 CIT0038 CIT0015 CIT0037 CIT0018 CIT0017 CIT0039 CIT0019 CIT0041 CIT0021 CIT0043 CIT0020 CIT0042 CIT0001 CIT0023 CIT0045 CIT0022 CIT0044 CIT0003 CIT0025 CIT0047 CIT0002 CIT0024 CIT0046 CIT0005 CIT0027 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 CIT0009 Herrera BB (CIT0040) 2018; 9 CIT0008 |
References_xml | – ident: CIT0014 doi: 10.1038/s41467-020-15562-9 – ident: CIT0044 doi: 10.1038/s41586-020-2571-7 – ident: CIT0025 doi: 10.1126/science.abc6284 – ident: CIT0042 doi: 10.1038/s41587-020-0631-z – ident: CIT0009 doi: 10.1016/j.molcel.2020.04.022 – ident: CIT0002 doi: 10.1056/NEJMoa2001017 – ident: CIT0019 doi: 10.1016/S1387-2656(05)11007-2 – ident: CIT0013 doi: 10.3390/v12050513 – ident: CIT0041 doi: 10.1371/journal.pone.0045851 – ident: CIT0020 doi: 10.21769/BioProtoc.2940 – ident: CIT0023 doi: 10.1080/22221751.2019.1682948 – ident: CIT0034 doi: 10.1073/pnas.77.7.3884 – ident: CIT0001 doi: 10.1038/s41586-020-2012-7 – ident: CIT0029 – ident: CIT0011 doi: 10.1016/j.cell.2020.06.043 – ident: CIT0033 doi: 10.1016/j.virol.2007.06.026 – ident: CIT0043 doi: 10.1016/j.cell.2020.06.025 – ident: CIT0006 doi: 10.1016/j.cell.2020.02.058 – ident: CIT0047 doi: 10.1016/j.chom.2020.11.012 – volume: 9 start-page: e00755 year: 2018 ident: CIT0040 publication-title: mBio contributor: fullname: Herrera BB – ident: CIT0015 doi: 10.1084/jem.20201181 – ident: CIT0016 doi: 10.1038/s41467-020-19808-4 – ident: CIT0021 doi: 10.1038/nbt.1918 – ident: CIT0039 doi: 10.1093/infdis/jiaa673 – ident: CIT0017 doi: 10.1007/s00259-008-0870-6 – ident: CIT0012 – ident: CIT0018 doi: 10.4161/cc.26985 – ident: CIT0022 doi: 10.1038/nmeth.2521 – ident: CIT0031 doi: 10.1038/s41591-021-01255-3 – ident: CIT0007 doi: 10.1073/pnas.0809524106 – ident: CIT0032 doi: 10.1006/viro.1995.1016 – ident: CIT0035 doi: 10.1016/j.celrep.2020.03.002 – ident: CIT0003 – ident: CIT0024 doi: 10.1038/s41467-019-13897-6 – volume: 28 start-page: 1 year: 2020 ident: CIT0004 publication-title: Nat Rev Microbiol contributor: fullname: V'kovski P – ident: CIT0026 doi: 10.1038/s41586-020-03041-6 – ident: CIT0030 doi: 10.1126/science.abf2946 – ident: CIT0010 doi: 10.1073/pnas.2003138117 – ident: CIT0038 doi: 10.1128/JVI.00556-18 – ident: CIT0045 doi: 10.1038/s41586-020-2548-6 – ident: CIT0036 doi: 10.1074/jbc.M114.610428 – ident: CIT0005 doi: 10.1126/science.abb2507 – ident: CIT0037 doi: 10.1073/pnas.0306446101 – ident: CIT0046 doi: 10.1038/s41423-020-00605-4 – ident: CIT0028 doi: 10.1016/j.cell.2020.12.015 – ident: CIT0008 doi: 10.1016/j.antiviral.2020.104742 – ident: CIT0027 doi: 10.1128/JCM.02107-20 |
SSID | ssj0000706414 |
Score | 2.3116934 |
Snippet | Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy.... |
SourceID | doaj pubmedcentral crossref pubmed informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 894 |
SubjectTerms | Ammonium Chloride - pharmacology Animals Antibodies, Viral - blood Antigen-Antibody Reactions Blotting, Western Chlorocebus aethiops Convalescence COVID-19 - blood COVID-19 - immunology Defective Viruses - genetics Genes, Reporter Genetic Vectors - immunology HEK293 Cells HIV-1 - genetics Humans Immunoglobulin G - immunology Lentivirus - genetics monomeric infrared fluorescent protein Mutagenesis, Site-Directed neutralization Neutralization Tests - methods Pandemics Point Mutation pseudovirus reporter SARS-CoV-2 SARS-CoV-2 - immunology Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - immunology Vero Cells |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gI8WZ5aQ5cXey148dxqagqJDhQinqLHD_ESiW7yib8D_4x4zhbJVx64ZjEsiaZieebsecbQt77qsE42UWqDBNUco_rIA8YqhilnfV-LV1ODXz5qi6u5Ofr6nrW6iufCSv0wOXDfVijD0qJCxOTlVIGZxy6eIysmE5G2hL4MDsLpsY1WKOr5fJYsmMYzoMz6SqHhGt-irim4kosnNHI2f8PY-nMLy3PTM6c0Pkj8nBCj7ApUj8m92L7hDwoqTcoFUVPyZ8NIBK8obltPLg2QKYkplNDnv3QQxuHMb9RKjABwWYP2ZsFwKvLzbdLerb7QdewP8Qh7H5vu-EA-Uh7aSYBv3IdRN7nAXyHLh9gh3Qz7LpCDAUj88O2BXeAsiERu2fk6vzT97MLOnVeoL4Ssqea2xRTLpRXPqhgdRJNkjI6o5JDjCKljcIyz4JViDeC5R6HJumCx3DRBPGcnLS7Nr4koBqdYnCCe-kk18H6iiXPdcOaxFgIK3J6VEG9LwQbNZ94S486q7PO6klnK_IxK-p2cObHHm-g1dST1dR3Wc2K2Lma635Mj6TSy6QWdwjwopjCrQgig0wr5IrohZEsZFw-abc_Ry5vg2JhCPrqf7zUa3I_y1kSRG_ISd8N8S1Cpr55N_4dfwFShhHH priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaW5YKEEG_KS3Pg6hLXTmIfECorViskOLAU7S1y_IBKJSlpguBn8I8Zx-6qQSAuHPOSxhnb88145htCnpm8Rj9ZO1rIjFPBDO6DzKKrIotSK2MWQofQwNt3xdlKvLnIL47InlAh_cDdH1270E9q1W3m37_-eIkL_kXKkHuOJg6BdR68vQWbI2TJEWRcIVcXAp31kM2XEP-4OZdog5nY1_L87euJlRrJ_H-jMj0wWNNkygPrdHqT3EiwEpZxHtwiR665Ta7HmBzEUqM75OcSECJuaOgnD7qxELiKaerUsx16aNwwBj5iaSYgCu0hmDkLeHW-fH9OT9qPdAHbnRts-23dDTsIue6xywR8CQUS4QAIcAxdyGwHvxnaLjJGwUgJsW5A7yCeVLjuLlmdvv5wckZTSwZqci56WjLlnQ8V9IWxhVWl57UXwmlZeI3gRQjluMpMZlWBQMQqZvBVL7Q16EdKy--R46Zt3AMCRV16ZzVnRmjBSqtMnnnDyjqrfZZZOyPzvQqqbWTeqFgiNN3rrAo6q5LOZuRVUNTly4E4e7zRdp-qtA7xSya9Z1w6r4QQVkuNiBEd9az0Uig2I-pQzVU_xk18bHJS8X8IcD9OhUsReECfiosZKSeTZCLj9Emz_jySfEsUC33Th_9jUI_ItSBnjBw9Jsd9N7gniKX6-um4On4BFiEaeA priority: 102 providerName: Scholars Portal – databaseName: Taylor & Francis Open Access dbid: 0YH link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9QwDI5guSAhxJvhpRy4dkkmbpochxWrERIcWBbBqUrzgJF221Ef_A_-MU7TjqZIiAPHtonkykn82bE_E_La5hX6ycZnUjGRAbd4DnKHroqShdHWrsHE0MCHj3J7Ce-_5nM2YTelVUYfOiSiiPGsjpvbVN2cEfcGTRoC6Tx6d2t-ihAlR1Bxk9xa47tIn8--bQ9hFlzREjjMtTt_m72wSiN5_x_UpUcGapk8eWSNzu-RuxOMpJuk9_vkhq8fkDspBkdTadFD8mtDERJeZbF_PMW_pZGbOJs68-yHntZ-GAMdqRSTIursaTRrjuLTxebTRXbWfMnWdN_5wTU_d-3Q0ZjbnrpK0OtYEBEvfCj-Qxsz2Wm4Gpo2MUTRkQJiV1PT0XQz4dtH5PL83eezbTa1YMhsLqDPCq6DD7FiXlonnS6CqAKAN0oGg2AFQHuhmWVOSwQeTnOLQwMYZ9FvVE48Jid1U_unhMqqCN4ZwS0Y4IXTNmfB8qJiVWDMuRU5nVVQ7hPTRsknAtNZZ2XUWTnpbEXeRkUdBkei7PFF034vp32HM7kKgQvlgwYAZ5RBhIiOOSuCAs1XRB-ruezHOElITU1K8Q8BnqSlcBBBRLSpBaxIsVgkCxmXX-rdj5HUW6FY6Is--w95npPb8TEFiF6Qk74d_EuETH31atwUvwEhag_l priority: 102 providerName: Taylor & Francis |
Title | A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter |
URI | https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.1925163 https://www.ncbi.nlm.nih.gov/pubmed/33929934 https://pubmed.ncbi.nlm.nih.gov/PMC8143625 https://doaj.org/article/2218ff138ef9444da8a14313307f8491 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBabPZSFUvrebNugQ69OpEi2pWMauoRCSul2y_ZkZD3aQOIEx-7_2H_ckWQvcS-FXgx-CMbMWPPNeOYbhN7rtIQ4WdkkE4QlnGrYB6mBUEVkuZJaz7nyqYH152x1yz_dpXdnKO17YULRvi4302q7m1abX6G28rDTs75ObPZlvRTg5AG3z0ZoBAZ6EqKH7TcHL0t5360jyAxcIADv1EeDczoFSJMCCLlAj5jHBpLxgUsKzP1_8ZaeeKdh5eSJK7p-ip50GBIvoqzP0JmtnqPHMQGHY1_RC3S_wIAHt4kfHo9VZbAnJk66sTyHtsGVbUOWI_ZhYoCcDfY-zWA4u1l8vUmW--_JHB-OtjX735u6PWJf2B5HSuCd74bwf3swvEPty9ix27b7OtJD4cD_sKmwOuL4W8LWL9Ht9cdvy1XSzV9IdMp4k-RUOut8u3ymTWZk7ljpOLdKZE4BUuFcWiaJJkZmgDqMpBoedVwZDUGjMOwVOq_2lb1EOCtzZ41iVHPFaW6kTonTNC9J6QgxZoymvQqKQ6TZKGjHXtqrr_DqKzr1jdEHr6iHhz1Ldriwr38Wna3ASiqco0xYJznnRgkFlgNROcmd4JKOkTxVc9GEJImLE00K9g8BXkdTeBChN6cxygdGMpBxeAcMPDB6dwZ99d8r36ALL1zMDb1F503d2neAlppygkbkx2oScg1wXHMxCd_LH_TLFl8 |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,24330,27514,27936,27937,53804,53806,59471,59472 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagHECqUHkvUPCBa0q8njx8XCqqLbQ90BaVU-T4UVYqySqb9H_wj5mJs6sNUsWBY-JYGmtszzeTmW8Y-2CSEv1k7aI0j2UEwuA9KCy6KnmaaWXMFDSFBk7P0vklfLlKrrZqYSitknxoH4gi-ruaDjcFo9cpcR_RpiGSTsi9m4oDxCgJoor77EGiIKMuBvGP-SbOgls6BQHr4p27Zo_MUs_e_xd36ZaFGmdPbpmjoz32eMCRfBYU_4Tdc9VTthuCcDzUFj1jv2ccMeFNRA3kOS6XEzlxNLTmWXYtr1zXRzpCLSZH2NlysmuW49P57Nt5dFh_j6Z8uXKdrW8XTbfilNwe2krwX1QRQX98OK6hoVR27m-6ugkUUbzngFhUXK94-DXhmufs8ujzxeE8GnowRCaR0EaZUN55KplPjU2tyrwsPYDTeeo1ohUA5aSKTWxVisjDKmHwUw_aGnQccytfsJ2qrtwrxtMy885qKQxoEJlVJom9EVkZlz6OrZ2wg7UKimWg2ijEwGC61llBOisGnU3YJ1LU5mNiyu5f1M11MRw8nCly74XMnVcAYHWuESKiZx5nPgclJkxtq7lo-0CJD11NCvkPAV6GrbARQRLcVBImLBttkpGM45Fq8bNn9c5RLHRGX_-HPO_Zw_nF6Ulxcnz29Q17REMhWvSW7bRN5_YRP7Xlu_6A_AHVlBNV |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgkRASWvFcytMHrl7s2nHsY1moymuFWBbBKXL8gEpLUqUJ_2P_MeM4qRokxIFj4kQaa2zPN-OZbxB6brMS_GTjiVSUE8EsnIPMgauiZG60tXNhYmjgw6lcnYu3X7Mxm3A7pFVGHzokooj-rI6be-PCmBH3AkwaAOksendzdgwQJQNQcRVdyzSctLCk6bfVLswCK1oKJsbanb_9PbFKPXn_H9SlewZqmjy5Z42Wt9DhACPxIun9NrriqzvoZorB4VRadBddLjBAwgsS-8djmC2O3MRk6Myz6Vpc-a4PdKRSTAyos8XRrDkMT2eLT2fkpP5C5niz9Z2rf62bbotjbnvqKoF_xoKIeOGDYQ5NzGTH4aKrm8QQhXsKiHWFzRanmwnf3EPny9efT1ZkaMFAbMZFS3Kmgw-xYl5aJ53OAy-DEN4oGQyAFSG055pa6rQE4OE0s_BpEMZZ8BuV4_fRQVVX_gHCssyDd4YzK4xgudM2o8GyvKRloNS5GToeVVBsEtNGwQYC01FnRdRZMehshl5GRe0-jkTZ_Yu6-V4M-w7-ZCoExpUPWgjhjDKAEMExp3lQQrMZ0vtqLto-ThJSU5OC_0OAo7QUdiLwiDY1FzOUTxbJRMbpSLX-0ZN6KxALfNGH_yHPM3T946tl8f7N6btH6EYcSbGix-igbTr_BNBTWz7t98dvDRQSfg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+real-time+and+high-throughput+neutralization+test+based+on+SARS-CoV-2+pseudovirus+containing+monomeric+infrared+fluorescent+protein+as+reporter&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Wen-Yang+Tsai&rft.au=Lauren+L.+Ching&rft.au=Szu-Chia+Hsieh&rft.au=Marian+E.+Melish&rft.date=2021-01-01&rft.pub=Taylor+%26+Francis+Group&rft.eissn=2222-1751&rft.volume=10&rft.issue=1&rft.spage=894&rft.epage=904&rft_id=info:doi/10.1080%2F22221751.2021.1925163&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2218ff138ef9444da8a14313307f8491 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon |